Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Adamson

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunctionB C Widemann, F M Balis, R F Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Rescue of experimental intrathecal methotrexate overdose with carboxypeptidase-G2P C Adamson, F M Balis, C L McCully, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group studyP C Adamson, B C Widemann, G H Reaman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancersS L Berg, S M Blaney, P C Adamson, et al.
Mayo Clinic Proceedings|February 1, 1996
Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2A S O'Marcaigh, C M Johnson, W A Smithson, et al.
Cancer Research|February 1, 1993
Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding proteinP C Adamson, J F Boylan, F M Balis, et al.
Cancer Research|September 15, 1995
A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancerP C Adamson, F M Balis, J E Belasco, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acidB C Widemann, E Sung, L Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancerP C Adamson, G Reaman, J Z Finklestein, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumorsP C Adamson, S Zimm, A H Ragab, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunctionB C Widemann, F M Balis, R F Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Rescue of experimental intrathecal methotrexate overdose with carboxypeptidase-G2P C Adamson, F M Balis, C L McCully, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group studyP C Adamson, B C Widemann, G H Reaman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancersS L Berg, S M Blaney, P C Adamson, et al.
Mayo Clinic Proceedings|February 1, 1996
Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2A S O'Marcaigh, C M Johnson, W A Smithson, et al.
Cancer Research|February 1, 1993
Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding proteinP C Adamson, J F Boylan, F M Balis, et al.
Cancer Research|September 15, 1995
A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancerP C Adamson, F M Balis, J E Belasco, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acidB C Widemann, E Sung, L Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancerP C Adamson, G Reaman, J Z Finklestein, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumorsP C Adamson, S Zimm, A H Ragab, et al.
Pageof 6